Oryzon Genomics News and Activities

Oryzon Genomics is a company listed under the stock ticker ORY (US).

View the org chart displaying its 17 main executives

Most searched biographies at Oryzon Genomics

• Carlos Buesa, Chairman of the Board and Chief Executive Officer
• Manuel Figueroa, Independent Director
• Luis Quintana, Director

Popular executive movements at Oryzon Genomics

• Rolando Gutiérrez-Esteinou has joined the company as Medical Director, Central Nervous System  (posted on February 17 2026).

Create your alert
to follow the executive moves at Oryzon Genomics.

Oryzon Genomics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).
• Rallybio and Avenzo Therapeutics have announced they will merge  (posted on June 1 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Oryzon Genomics

Social media about Oryzon Genomics

• Oryzon Genomics on Wikipedia, Google News & Yahoo Finance
• Oryzon Genomics on LinkedIn, X (Twitter) & YouTube